Executive compensation details for the chief executive officer of Relay Therapeutics—including base salary figures, annual cash performance bonuses, and long-term equity incentive stock awards—are documented precisely in official proxy statements filed annually with the Securities and Exchange Commission. A typical biotechnology CEO compensation structure combines a fixed base salary with substantial equity grants aligned directly with long-term shareholder value creation and clinical milestone achievements.